Skip to content
DWT logo
People Expertise Insights
About Locations Careers
Search
People
Expertise
Insights
About
Locations
Careers
Search
Presentations

Moderator, "China: Tomorrow's Biggest CBD Market," Global Go

11.17.20
Share
Print this page
The liberalization of hemp regulations in China today is reminiscent of early cannabis legalization in North America in 2013. While THC remains strictly prohibited in China, the recent rapid growth of the worldwide CBD market has prompted the Chinese government to develop the legal framework necessary to enable the domestic production, and some forms of consumption, of non-psychoactive cannabinoids. 

Drawing parallels from Western markets, Heming Xu joined a panel of industry experts to examine the expected acceleration in the development of the Chinese CBD industry - from hemp cultivation all the way to CBD consumption - in the coming years. The structural advantages that have made China the world's manufacturing center extend to CBD production, and China's consumption capacity, with 1.4 billion increasingly affluent consumers, matching and even surpassing the US in several categories, leads us to believe that China is the world's largest emerging market for CBD.

Related Articles

DWT logo
©1996-2022 Davis Wright Tremaine LLP. ALL RIGHTS RESERVED. Attorney Advertising. Prior results do not guarantee a similar outcome.
NAVIGATE
Home People Expertise Insights
About Locations Careers Events Blogs
STAY CONNECTED

Subscribe to stay informed.

Subscribe
Employees
DWT Collaborate
EEO
Affiliations
Legal notices
Privacy policy
©1996-2022 Davis Wright Tremaine LLP. ALL RIGHTS RESERVED. Attorney Advertising. Prior results do not guarantee a similar outcome.
Close
Close

CAUTION - Before you proceed, please note: By clicking “accept” you agree that our review of the information contained in your e-mail and any attachments will not create an attorney-client relationship, and will not prevent any lawyer in our firm from representing a party in any matter where that information is relevant, even if you submitted the information in good faith to retain us.